Please login to the form below

Not currently logged in
Email:
Password:

Bexsero

This page shows the latest Bexsero news and features for those working in and with pharma, biotech and healthcare.

GSK doses first patients in phase 3 meningitis vaccine trial

GSK doses first patients in phase 3 meningitis vaccine trial

The studies will aim to enrol 3, 650 participants, and will evaluate the safety, tolerability and immunogenicity of MenABCWY compared to Bexsero and Menveo, GSK’s licensed meningitis vaccine products.

Latest news

More from news
Approximately 9 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    When GSK acquired two additional rival meningitis vaccines from Novartis, namely Menveo and Bexsero, the European Commission and other antitrust regulators were concerned that this gave GSK too much power in

  • Pharma deals during April 2014 Pharma deals during April 2014

    franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....